Skip to content
Tridihexethyl
Pathilon (tridihexethyl) is a small molecule pharmaceutical. Tridihexethyl was first approved as Pathilon on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Tridihexethyl chloride
Tradename
Company
Number
Date
Products
PATHILONLederle LaboratoriesN-009489 DISCN1982-01-01
1 products
PATHILONLederle LaboratoriesN-009729 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A03: Drugs for functional gastrointestinal disorders
— A03A: Drugs for functional gastrointestinal disorders
— A03AB: Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders
— A03AB08: Tridihexethyl
HCPCS
No data
Clinical
Clinical Trials
167 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental plaqueD003773—1103115
Acne vulgarisD000152EFO_0003894L701117110
Facial painD005157R51.9131159
GingivitisD005891K05.10——2619
Surgical wound infectionD013530——2316
Periodontal diseasesD010510K05.6——3115
MelanosisD008548EFO_0003963L81.11——113
Seborrheic dermatitisD012628L21———112
Aggressive periodontitisD010520EFO_0006342K05.2———1—1
Ulcerative colitisD003093EFO_0000729K51———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Temporomandibular joint disordersD013705M26.6333—1218
Gingival diseasesD005882K05.1——6——6
PsoriasisD011565EFO_0000676L40—21—14
Cardiovascular diseasesD002318EFO_0000319I98111——2
Peri-implantitisD057873EFO_1001390——1—12
Covid-19D000086382U07.1—11——2
InfertilityD007246EFO_0000545—11——1
ElectromyographyD004576—11——1
CannabisD002188—11——1
PeriodontitisD010518EFO_0000649K05.3——1——1
Show 3 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep bruxismD020186G47.6311——35
Healthy volunteers/patients—41———4
Coronavirus infectionsD018352EFO_0007224B34.2—1———1
Arsenic poisoningD020261T57.0—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomatognathic diseasesD009057K08.91————1
Obstructive sleep apneaD020181EFO_0003918G47.331————1
Chronic diseaseD0029081————1
Craniomandibular disordersD0172711————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental cariesD003731EFO_0003819K02————44
BruxismD002012F45.8————33
MyalgiaD063806HP_0003326M79.1————22
PainD010146EFO_0003843R52————22
Personal satisfactionD010549————22
Chronic painD059350HP_0012532————22
PulpitisD011671EFO_1001139K04.0————22
Postoperative painD010149G89.18————22
Edentulous jawD007575————22
Edentulous mouthD009066————22
Show 48 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTRIDIHEXETHYL
INN—
Description
Tridihexethyl is a tertiary alcohol and a quaternary ammonium ion. It has a role as an anti-ulcer drug, a muscarinic antagonist and an antispasmodic drug.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1
Identifiers
PDB—
CAS-ID60-49-1
RxCUI38617
ChEMBL IDCHEMBL1201354
ChEBI ID9701
PubChem CID20299
DrugBankDB00505
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 24 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
868 adverse events reported
View more details